- Review indications for pharmacological treatment of pediatric onset psychiatric disorders.
- Discuss guidelines for treatment of pediatric onset psychiatric disorders.
- Examine selected classic pharmacological studies and recent research highlights to apply to child and adolescent clinical practice.
- Understand benefits and risks of recommended psychopharmacological treatments for children and adolescents.
Watch the Presentation
View the Learner Notification
Click here to claim your credit
[/colorsection] [center] [colorsection bgcolor=”darkbluebg”]About the Speaker
[one_third]
[/one_third]
[two_third_last]
Presented by: Barbara J. Coffey, MD, MS
Professor and Chairman of the Department of Psychiatry and Behavioral Sciences
University of Miami | Miller School of Medicine
Barbara J. Coffey, MD, MS, is a distinguished Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. She also serves as Chief of the Division of Child and Adolescent Psychiatry since 2017 and Director of the UHealth Tourette Center of Excellence since 2019.
Dr. Coffey is internationally recognized for her expertise in tics, Tourette Syndrome, and related disorders such as ADHD and OCD. Before joining the University of Miami, she held significant positions at prestigious institutions like Harvard Medical School, McLean Hospital, Massachusetts General Hospital, and the Icahn School of Medicine at Mount Sinai. Her research focuses on the clinical course, psychiatric comorbidity, phenomenology, and novel treatments of Tourette’s Disorder, and she has authored over 150 peer-reviewed manuscripts and book chapters.
Dr. Coffey’s educational background includes a fellowship in Child and Adolescent Psychiatry from Tufts University School of Medicine and psychoanalytic training from the Boston Psychoanalytic Society. She has been honored by the Tourette Association of America for her extensive work and dedication to improving the quality of life for individuals with Tourette Syndrome and related disorders.
[/two_third_last]
[/colorsection]
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Galen Mental Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Barbara J. Coffey, MD, MS
Professor and Chairman of the Department of Psychiatry and Behavioral Sciences
University of Miami | Miller School of Medicine
July 19, 2024
- Review indications for pharmacological treatment of pediatric onset psychiatric disorders.
- Discuss guidelines for treatment of pediatric onset psychiatric disorders.
- Examine selected classic pharmacological studies and recent research highlights to apply to child and adolescent clinical practice.
- Understand benefits and risks of recommended psychopharmacological treatments for children and adolescents.
Video: Watch the Presentation
Presented by:Barbara J. Coffey, MD, MS
Professor and Chairman of the Department of Psychiatry and Behavioral Sciences
University of Miami | Miller School of Medicine
Barbara J. Coffey, MD, MS, is a distinguished Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. She also serves as Chief of the Division of Child and Adolescent Psychiatry since 2017 and Director of the UHealth Tourette Center of Excellence since 2019.
Dr. Coffey is internationally recognized for her expertise in tics, Tourette Syndrome, and related disorders such as ADHD and OCD. Before joining the University of Miami, she held significant positions at prestigious institutions like Harvard Medical School, McLean Hospital, Massachusetts General Hospital, and the Icahn School of Medicine at Mount Sinai. Her research focuses on the clinical course, psychiatric comorbidity, phenomenology, and novel treatments of Tourette’s Disorder, and she has authored over 150 peer-reviewed manuscripts and book chapters.
Dr. Coffey’s educational background includes a fellowship in Child and Adolescent Psychiatry from Tufts University School of Medicine and psychoanalytic training from the Boston Psychoanalytic Society. She has been honored by the Tourette Association of America for her extensive work and dedication to improving the quality of life for individuals with Tourette Syndrome and related disorders.
Joint Accreditation Statement:
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Galen Mental Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
